Barclays Capital today reaffirms its overweight investment rating on LondonMetric Property (LON:LMP) and raised its price target to 220p (from 210p).

Broker Forecasts data provided...

Barclays Capital today reaffirms its equal weight investment rating on Grainger PLC (LON:GRI) and raised its price target to 270p (from 260p).

Broker Forecasts data...

Barclays Capital today downgrades its investment rating on Shaftesbury (LON:SHB) to underweight (from equal weight) and cut its price target to 740p (from 800p).

Broker...

UBS today reaffirms its sell investment rating on Meggitt PLC (LON:MGGT) and raised its price target to 530p (from 494p).

Broker Forecasts data provided by...

UBS today upgrades its investment rating on Bodycote PLC (LON:BOY) to buy (from neutral) and raised its price target to 1000p (from 845p).

Broker Forecasts...

UBS today reaffirms its neutral investment rating on BAE Systems Plc (LON:BA.) and raised its price target to 576p (from 530p).

Broker Forecasts data provided...

“There’s plenty for investors to fret about over the next few days and it doesn’t look like they’re feeling too positive about life, with the...

UBS today upgrades its investment rating on QinetiQ Group PLC (LON:QQ.) to neutral (from sell) and raised its price target to 335p (from 260p).

Broker...

UBS today reaffirms its buy investment rating on Rolls-Royce Group PLC (LON:RR.) and cut its price target to 938p (from 950p).

Broker Forecasts data provided...

Futura Medical said the European phase 3 clinical trial of its erectile dysfunction treatment had not met its primary goals versus a placebo.

FM57,...